Susquehanna International Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Susquehanna International Group’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,900	Closed	-$34K	–	14538
2022 Q2	$34K	Sell	13,900 -66,300	-83%	-$184K	﹤0.01%	12169
2022 Q1	$324K	Sell	80,200 -22,000	-22%	-$121K	﹤0.01%	10091
2021 Q4	$819K	Sell	102,200 -71,500	-41%	-$838K	﹤0.01%	7823
2021 Q3	$3.35M	Buy	173,700 +12,400	+8%	+$217K	﹤0.01%	4725
2021 Q2	$2.23M	Buy	+161,300	New	+$1.91M	﹤0.01%	5669

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Susquehanna International Group's PLXP Position: Q2 2023 in Review

Susquehanna International Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 52,728 shares — an estimated $6.86K sold.

Susquehanna International Group first reported a position in PLXP in Q2 2017 and held it in 11 quarters. The position peaked at $3.3M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

Susquehanna International Group reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 52,728 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $6.86K.
Susquehanna International Group first reported a position in PLx Pharma Inc. Common Stock in Q2 2017 and held it in 11 quarters.
Susquehanna International Group's PLx Pharma Inc. Common Stock position peaked at $3.3M in Q3 2021.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.